Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance
Share
[aggregation-styles]
Bloomberg Subscription
Bloomberg Subscription
Eli Lilly & Co.’s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating Covid-19, widening access to a treatment that early data suggests is effective in keeping people infected with the coronavirus out of the hospital.
The Food and Drug Administration authorized the treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adult and pediatric patients, the agency said on its website.
Shares of Eli Lilly gained 4.5% in late trading on Monday. Through the close, the stock had advanced 8.3% so far this year.
By Riley Griffin | 9 Nov 2020
RELATED TOPICS:
White House Fires USAID Inspector General After Warning About Funding Oversight
Politics /
13 hours ago
Red, White, and Blueland? GOP Congressman Proposes Bill to Rename Greenland
Politics /
14 hours ago
White House Bars AP Reporter From Oval Office Because of AP Style Policy on ‘Gulf of America’
Politics /
15 hours ago
Trump Steel, Aluminum Tariffs Likely to Drive up Car Costs, Industry Leaders Say
Economy /
15 hours ago
After Criminal Case Tossed, Madec Fights to Get Fresno CC Classroom Job Back
Courts /
15 hours ago
Fresno Crash Kills Pedestrian. Driver Cooperates With Police.
Local /
18 hours ago
Latest
Videos

Crime /
13 hours ago
California Man Calls 375 Hoax Threats in Swatting Spree Will Face Prison Time

Politics /
13 hours ago
White House Fires USAID Inspector General After Warning About Funding Oversight

Politics /
14 hours ago
Red, White, and Blueland? GOP Congressman Proposes Bill to Rename Greenland

Politics /
15 hours ago
White House Bars AP Reporter From Oval Office Because of AP Style Policy on ‘Gulf of America’

Economy /
15 hours ago
Trump Steel, Aluminum Tariffs Likely to Drive up Car Costs, Industry Leaders Say

Courts /
15 hours ago
After Criminal Case Tossed, Madec Fights to Get Fresno CC Classroom Job Back

Business /
5 days ago